TrialPath
Recruiting

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

NCT07120503 · Windward Bio
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants With Moderate or Severe Asthma
About this study
The main purpose of this global study is to assess whether WIN378, an ultra-long-acting medicine for people with asthma, reduces the annualized rate of asthma exacerbations using the doses identified from an interim analysis of Part A of the study. WIN378 blocks the action of a protein called TSLP, which causes inflammation in the lung and may contribute to asthma control and symptoms. The study has two parts. Part A is evaluating three doses of WIN378 in adults with moderate or severe asthma to evaluate: 1) how WIN378 is handled by your body (pharmacokinetics), 2) the safety of WIN378 and 3) efficacy (markers of asthma inflammation (in your breath and in your blood), lung function and asthma control. An interim analysis of Part A data was used to select two doses of WIN378 for Part B. Part B will compare the two selected doses of WIN378 with placebo in adults with severe uncontrolled asthma. The main purpose of Part B is to assess whether WIN378 reduces the annualized rate of asthma exacerbations. In addition, it aims to evaluate whether WIN378 can improve lung function, quality of life, asthma control and other important efficacy measures. Furthermore the study will evaluate the safety and tolerability of WIN378 versus placebo.
Eligibility criteria
Inclusion Criteria: * Written Informed Consent Form * Females that are not pregnant or breastfeeding with following condition: not a woman of childbearing potential or woman of childbearing potential using a highly effective contraception method * Physician-diagnosis of asthma and documented evidence of airway reversibility during prior 24 months or during screening * Airflow limitation as indicated by pre-BD FEV1 value: PART A of ≥ 30% and ≤ 90%, predicted; PART B of ≥ 30% and ≤ 80%, predicted * PART A Low, medium-, or high-dose ICS and ≥1 maintenance asthma controller medication (LABA/LTRA/LAMA/chromones/theophylline) * PART B: medium-, or high-dose ICS and ≥1 maintenance asthma controller medication (LABA/LTRA/LAMA/chromones/theophylline) * Part B: History of at least of 2 asthma exacerbations within 12 months before V1 Exclusion Criteria: * Participants with a known, pre-existing, clinically important lung condition other than asthma * Tuberculosis or treatment required for tuberculosis within 12 months * Current or former smokers ≥10 pack years * History of cancer * Receipt of any marketed biologic agent within 4 months or 5 half-lives prior to screening; Receipt of immunoglobulin or blood products within 30 days prior to screening or during the Screening Run-in period; Receipt of any live or attenuated vaccines within 15 days prior to screening * Helminth infection within 24 weeks prior to screening * Use of immunosuppressive medication within 3 months prior to Screening Visit or during the Screening Run-in period * Participants who are pregnant, lactating or breastfeeding
Study design
Enrollment target: 600 participants
Allocation: randomized
Masking: double
Age groups: adult, older_adult
Timeline
Starts: 2025-07-24
Estimated completion: 2028-11-23
Last updated: 2026-10-21
Interventions
Drug: WIN378Drug: Placebo
Primary outcomes
  • • PART A: Number of participants with treatment-emergent adverse events (TEAEs) during the study (Week 0 - Week 60)
  • • PART A: Number of participants with treatment-emergent serious adverse events (TESAEs) during the study (Week 0 - Week 60)
  • • PART A: Number of participants with abnormal vital signs during the study (Week 0 - Week 60)
Sponsor
Windward Bio · industry
Contacts & investigators
ContactAyshea Kring · contact · clinical.trial.enquiry@windwardbio.com · +41 61 551 71 39
InvestigatorOmar Khwaja, MD · study_director, Windward Bio
All locations (73)
WB Contracted Clinical Research SiteActive Not Recruiting
Los Angeles, California, United States
WB Contracted Clinical Research SiteActive Not Recruiting
San Jose, California, United States
WB Contracted Clinical Research SiteRecruiting
Melbourne, Florida, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Miami, Florida, United States
WB Contracted Clinical Research SiteActive Not Recruiting
White Marsh, Maryland, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Stow, Massachusetts, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Detroit, Michigan, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Richfield, Minnesota, United States
WB Contracted Clinical Research SiteActive Not Recruiting
St Louis, Missouri, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Bellevue, Nebraska, United States
WB Contracted Clinical Research SiteRecruiting
Toledo, Ohio, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Edmond, Oklahoma, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Pittsburgh, Pennsylvania, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Charleston, South Carolina, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Spartanburg, South Carolina, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Austin, Texas, United States
WB Contracted Clinical Research SiteActive Not Recruiting
El Paso, Texas, United States
WB Contracted Clinical Research SiteRecruiting
McKinney, Texas, United States
WB Contracted Clinical Research SiteActive Not Recruiting
San Antonio, Texas, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Tyler, Texas, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Richmond, Virginia, United States
WB Contracted Clinical Research SiteActive Not Recruiting
Buenos Aires, Buenos Aires F.D., Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
Buenos Aires, Buenos Aires F.D., Argentina
WB Contracted Clinical Research SiteRecruiting
Buenos Aires, Buenos Aires F.D., Argentina
WB Contracted Clinical Research SiteRecruiting
Buenos Aires, Buenos Aires F.D., Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
Buenos Aires, Buenos Aires F.D., Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
Buenos Aires, Buenos Aires F.D., Argentina
WB Contracted Clinical Research SiteRecruiting
Córdoba, Córdoba Province, Argentina
WB Contracted Clinical Research SiteRecruiting
Paraná, Entre Ríos Province, Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
Rosario, Santa Fe Province, Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
Rosario, Santa Fe Province, Argentina
WB Contracted Clinical Research SiteRecruiting
Santa Fe, Santa Fe Province, Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
San Miguel de Tucumán, Tucumán Province, Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
San Miguel de Tucumán, Tucumán Province, Argentina
WB Contracted Clinical Research SiteRecruiting
San Miguel de Tucumán, Tucumán Province, Argentina
WB Contracted Clinical Research SiteActive Not Recruiting
Brookvale, New South Wales, Australia
WB Contracted Clinical Research SiteActive Not Recruiting
Coffs Harbour, New South Wales, Australia
WB Contracted Clinical Research SiteActive Not Recruiting
Maroubra, New South Wales, Australia
WB Contracted Clinical Research SiteActive Not Recruiting
Miranda, New South Wales, Australia
WB Contracted Clinical Research SiteActive Not Recruiting
Wollongong, New South Wales, Australia
WB Contracted Clinical Research SiteActive Not Recruiting
Birtinya, Queensland, Australia
WB Contracted Clinical Research SiteActive Not Recruiting
North Altona, Victoria, Australia
WB Contracted Clinical Research SiteActive Not Recruiting
Sofia, Grad Sofia, Bulgaria
WB Contracted Clinical Research SiteActive Not Recruiting
Lovech, Lovech, Bulgaria
WB Contracted Clinical Research SiteActive Not Recruiting
Rousse, Ruse, Bulgaria
WB Contracted Clinical Research SiteActive Not Recruiting
Sofia, Sofia, Bulgaria
WB Contracted Clinical Research SiteActive Not Recruiting
Sofia, Sofia, Bulgaria
WB Contracted Clinical Research SiteActive Not Recruiting
Pessac, Bordeaux, France
WB Contracted Clinical Research SiteActive Not Recruiting
Dijon, Côte-dOr, France
WB Contracted Clinical Research SiteActive Not Recruiting
Montpellier, Hérault, France
WB Contracted Clinical Research SiteActive Not Recruiting
La Tronche, Isère, France
WB Contracted Clinical Research SiteActive Not Recruiting
Nantes, Loire-Atlantique, France
WB Contracted Clinical Research SiteActive Not Recruiting
Berlin, Loire-Atlantique, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
München, Loire-Atlantique, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Bendorf, Rhineland-Palatinate, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Lübeck, Schleswig-Holstein, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Darmstadt, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Frankfurt am Main, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Frankfurt am Main, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Leipzig, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Mainz, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
München, Germany
WB Contracted Clinical Research SiteActive Not Recruiting
Chiclana de la Frontera, Cádiz, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
Madrid, Entre Ríos, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
San Sebastián, Guipúzcoa, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
Madrid, Madrid, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
Pozuelo de Alarcón, Madrid, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
Benalmádena, Málaga, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
Málaga, Málaga, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
Seville, Sevilla, Spain
WB Contracted Clinical Research SiteActive Not Recruiting
Linköping, Ostergotlands, Sweden
WB Contracted Clinical Research SiteActive Not Recruiting
Malmö, Skåne County, Sweden
WB Contracted Clinical Research SiteActive Not Recruiting
Stockholm, Stockholm County, Sweden